Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Accumulated Depreciation & Amortization (2020 - 2022)

Historic Accumulated Depreciation & Amortization for Terns Pharmaceuticals (TERN) over the last 3 years, with Q4 2022 value amounting to $1.4 million.

  • Terns Pharmaceuticals' Accumulated Depreciation & Amortization rose 1831.22% to $1.4 million in Q4 2022 from the same period last year, while for Dec 2022 it was $1.4 million, marking a year-over-year increase of 1831.22%. This contributed to the annual value of $1.4 million for FY2022, which is 1831.22% up from last year.
  • Latest data reveals that Terns Pharmaceuticals reported Accumulated Depreciation & Amortization of $1.4 million as of Q4 2022, which was up 1831.22% from $1.2 million recorded in Q4 2021.
  • Terns Pharmaceuticals' 5-year Accumulated Depreciation & Amortization high stood at $1.4 million for Q4 2022, and its period low was $689000.0 during Q4 2020.
  • In the last 3 years, Terns Pharmaceuticals' Accumulated Depreciation & Amortization had a median value of $1.2 million in 2021 and averaged $1.1 million.
  • As far as peak fluctuations go, Terns Pharmaceuticals' Accumulated Depreciation & Amortization soared by 7198.84% in 2021, and later soared by 1831.22% in 2022.
  • Over the past 3 years, Terns Pharmaceuticals' Accumulated Depreciation & Amortization (Quarter) stood at $689000.0 in 2020, then skyrocketed by 71.99% to $1.2 million in 2021, then rose by 18.31% to $1.4 million in 2022.
  • Its last three reported values are $1.4 million in Q4 2022, $1.2 million for Q4 2021, and $689000.0 during Q4 2020.